| |
| |
|
| Insider
Information: |
Ward Shane |
| Relationship: |
COO & CLO |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
522,205 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,223 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
522,205 |
|
|
| Total
Value |
$8,223 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aravive Inc |
ARAV |
SVP and General Counsel |
2018-02-08 |
201,556 |
2016-01-28 |
0 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Sr VP and Chief Legal SO |
2020-05-29 |
1,879 |
2018-05-29 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
COO & CLO |
2024-03-15 |
318,770 |
2022-03-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDTX |
Cidara Therapeutics, Inc. |
COO & CLO |
• – – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
318,770 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
COO & CLO |
• – – |
2024-03-11 |
4 |
S |
$0.67 |
$13,713 |
D/D |
(20,473) |
198,770 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
COO & CLO |
• – – |
2023-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
126,667 |
211,243 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
COO & CLO |
• – – |
2023-03-13 |
4 |
S |
$1.53 |
$6,623 |
D/D |
(4,329) |
84,576 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
CHIEF LEGAL OFFICER |
• – – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
104,027 |
104,027 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
CHIEF LEGAL OFFICER |
• – – |
2022-03-31 |
4 |
D |
$0.83 |
$19,191 |
D/D |
(23,122) |
80,905 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Sr VP and Chief Legal SO |
• – – |
2020-05-29 |
4 |
D |
$7.63 |
$816 |
D/D |
(107) |
1,879 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Sr. VP and General Counsel |
• – – |
2019-08-29 |
4 |
B |
$1.23 |
$9,822 |
D/D |
8,000 |
18,294 |
2.74 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Sr. VP and General Counsel |
• – – |
2019-05-29 |
4 |
D |
$2.09 |
$2,226 |
D/D |
(1,065) |
8,935 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Sr. VP and General Counsel |
• – – |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2018-02-08 |
4 |
S |
$1.80 |
$7,412 |
D/D |
(4,118) |
201,556 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
93,100 |
205,674 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
112,574 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-10-19 |
4 |
S |
$2.55 |
$1,979 |
D/D |
(776) |
92,574 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
57,000 |
93,350 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-03-15 |
4 |
S |
$19.02 |
$14,760 |
D/D |
(776) |
36,350 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-03-14 |
4 |
S |
$19.00 |
$24,035 |
D/D |
(1,265) |
37,126 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-01-30 |
4 |
S |
$13.85 |
$20,418 |
D/D |
(1,474) |
38,391 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP and General Counsel |
• – – |
2017-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
20,600 |
39,865 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP, Legal and Compliance |
• – – |
2016-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
19,265 |
0 |
- |
|
| ARAV |
Aravive Inc |
SVP, Legal and Compliance |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
14,265 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
